CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lophos Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lophos Holdings Inc
620 - 1111 Melville Street
Phone: (604) 401-6656p:604 401-6656 VANCOUVER, BC  V6E 3V6  Canada Ticker: MESCMESC
Business Summary
Lophos Holdings Inc. is a Canada-based company, which is engaged in the cultivation, research and sale of Lophophora williamsii (peyote cactus). The Company is also engaged in the research and development of compounds derived from the peyote cactus. Its cultivated peyote cactus will be used by the Company to conduct pre-clinical research and development in Canada either directly through a Controlled Substance Dealers License (CSDL) at its Napanee facility, or indirectly with one or more third-party partners. The Company's CSDL licensing includes the development of intellectual property related to the chemical composition of peyote and the custom formulation of Mescaline and related compounds and the research and development of drug delivery systems for Mescaline and other related molecules. It also operates a Health Canada licensed analytical testing and research and development institution, to conduct pre-clinical research and development through Sigma Analytical Services Inc.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20243/31/2024Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jacqueline C.Lupo 37 12/23/2021 12/23/2021
Chief Financial Officer RemantraSheopaul 36 1/6/2022 1/6/2022
Director SolomonElimimian 36 10/14/2020 10/14/2020
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1 (As of 8/11/2023)
Outstanding Shares: 85,859,673 (As of 3/31/2024)
Stock Exchange: CNQ


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024